111 related articles for article (PubMed ID: 21299688)
1. A multicentre surveillance study on the characteristics, bacterial aetiologies and in vitro antibiotic susceptibilities in patients with acute exacerbations of chronic bronchitis.
Hui DS; Ip M; Ling T; Chang SC; Liao CH; Yoo CG; Kim DK; Yoon HI; Udompanich V; Mogmeud S; Muttalif R; Salleh AM; Roa C; Mendoza M; Fajardo-Ang C; Soepandi P; Isbaniah F; Burhan E; Sudarmono P; Mangunnegoro H; Liu HH
Respirology; 2011 Apr; 16(3):532-9. PubMed ID: 21299688
[TBL] [Abstract][Full Text] [Related]
2. Discrepancy between antibiotics administered in acute exacerbations of chronic bronchitis and susceptibility of isolated pathogens in respiratory samples: multicentre study in the primary care setting.
Querol-Ribelles JM; Molina J; Naberan K; Esteban E; Herreras A; Garcia-de-Lomas J
Int J Antimicrob Agents; 2006 Nov; 28(5):472-6. PubMed ID: 17046209
[TBL] [Abstract][Full Text] [Related]
3. Study entry microbiology in patients with acute bacterial exacerbation of chronic bronchitis in a clinical trial stratifying by disease severity.
Kahn JB; Khashab M; Ambruzs M
Curr Med Res Opin; 2007 Jan; 23(1):1-7. PubMed ID: 17261234
[TBL] [Abstract][Full Text] [Related]
4. Sputum colour and bacteria in chronic bronchitis exacerbations: a pooled analysis.
Miravitlles M; Kruesmann F; Haverstock D; Perroncel R; Choudhri SH; Arvis P
Eur Respir J; 2012 Jun; 39(6):1354-60. PubMed ID: 22034649
[TBL] [Abstract][Full Text] [Related]
5. Antibiotics in acute exacerbations of chronic bronchitis.
Sethi S
Expert Rev Anti Infect Ther; 2010 Apr; 8(4):405-17. PubMed ID: 20377336
[TBL] [Abstract][Full Text] [Related]
6. Appropriate outpatient treatment of acute bacterial exacerbations of chronic bronchitis.
Martinez FJ; Anzueto A
Am J Med; 2005 Jul; 118 Suppl 7A():39S-44S. PubMed ID: 15993676
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic treatment for patients with acute exacerbations of chronic bronchitis.
Pacios E; Gestoso I; Villarroel P
Clin Microbiol Infect; 2007 Jul; 13(7):747-8. PubMed ID: 17441978
[No Abstract] [Full Text] [Related]
8. Clinical significance of the infection-free interval in the management of acute bacterial exacerbations of chronic bronchitis.
Chodosh S
Chest; 2005 Jun; 127(6):2231-6. PubMed ID: 15947342
[TBL] [Abstract][Full Text] [Related]
9. Acute exacerbations of chronic bronchitis: new developments concerning microbiology and pathophysiology--impact on approaches to risk stratification and therapy.
Sethi S; Murphy TF
Infect Dis Clin North Am; 2004 Dec; 18(4):861-82, ix. PubMed ID: 15555829
[TBL] [Abstract][Full Text] [Related]
10. [Chronic bronchitis. When to use antibiotics?].
MMW Fortschr Med; 2001 Dec; 143(51-52):51. PubMed ID: 11824170
[No Abstract] [Full Text] [Related]
11. Five-day moxifloxacin therapy compared with 7-day co-amoxiclav therapy for the treatment of acute exacerbation of chronic bronchitis.
Starakis I; Gogos CA; Bassaris H
Int J Antimicrob Agents; 2004 Feb; 23(2):129-37. PubMed ID: 15013037
[TBL] [Abstract][Full Text] [Related]
12. Acute exacerbation of chronic bronchitis. Guidelines for antibiotic selection.
Schwarzmann SW
Postgrad Med; 2000 Dec; 108(7 Suppl Contemporaty):25-9. PubMed ID: 19667546
[TBL] [Abstract][Full Text] [Related]
13. Managing patients with recurrent acute exacerbations of chronic bronchitis: a common clinical problem.
Sethi S; File TM
Curr Med Res Opin; 2004 Oct; 20(10):1511-21. PubMed ID: 15462685
[TBL] [Abstract][Full Text] [Related]
14. Indicators of bacterial infection in patients with acute exacerbation of chronic bronchitis for application in clinical trials of antibacterial drugs.
Burley CJ; Masterton RG; Lovell DP
J Infect; 2007 Sep; 55(3):226-32. PubMed ID: 17640738
[TBL] [Abstract][Full Text] [Related]
15. Short-course therapy of acute bacterial exacerbation of chronic bronchitis: a double-blind, randomized, multicenter comparison of extended-release versus immediate-release clarithromycin.
Nalepa P; Dobryniewska M; Busman T; Notario G
Curr Med Res Opin; 2003; 19(5):411-20. PubMed ID: 13678478
[TBL] [Abstract][Full Text] [Related]
16. Changing bacterial isolates and antibiotic sensitivities of purulent dacryocystitis.
Briscoe D; Rubowitz A; Assia E
Orbit; 2005 Mar; 24(1):29-32. PubMed ID: 15764113
[TBL] [Abstract][Full Text] [Related]
17. Inhaled tobramycin in non-cystic fibrosis patients with bronchiectasis and chronic bronchial infection with Pseudomonas aeruginosa.
Drobnic ME; Suñé P; Montoro JB; Ferrer A; Orriols R
Ann Pharmacother; 2005 Jan; 39(1):39-44. PubMed ID: 15562142
[TBL] [Abstract][Full Text] [Related]
18. A disease model descriptive of progression between chronic obstructive pulmonary disease exacerbations and community-acquired pneumonia: roles for underlying lung disease and the pharmacokinetics/pharmacodynamics of the antibiotic.
File TM; Monte SV; Schentag JJ; Paladino JA; Klugman KP; Lavin B; Yu VL; Singer ME; Adelman MH
Int J Antimicrob Agents; 2009 Jan; 33(1):58-64. PubMed ID: 18835762
[TBL] [Abstract][Full Text] [Related]
19. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
Werarak P; Kiratisin P; Thamlikitkul V
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
[TBL] [Abstract][Full Text] [Related]
20. Prospective observational study of patient-reported outcomes for azithromycin versus usual care in the treatment of bacterial acute exacerbation of chronic bronchitis.
Milstone A; Patsimas J; Farzan D; Castaldo R; Singh H; Feurer I; Harnett J; Luke DR;
Clin Ther; 2005 Jun; 27(6):926-39. PubMed ID: 16117993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
